JACC: Cardiooncology

Article	Citations
Cardiac Tumors	182
Cardiovascular Effects of CAR T Cell Therapy	76
Cardiovascular Risk Factors Are Associated With Future Cancer	74
Cardiovascular Manifestations From Therapeutic Radiation	71
Past, Present, and Future of Radiation-Induced Cardiotoxicity: Refinements in Targeting, Surveillance, and Risk Stratification	70
The Novel Coronavirus Disease (COVID-19) Threat for Patients With Cardiovascular Disease and Cancer	70
The Evolving Immunotherapy Landscape and the Epidemiology, Diagnosis, and Management of Cardiotoxicity	67
Venous and Arterial Thromboembolism in Patients With Cancer	66
CAR T Cell Therapy–Related Cardiovascular Outcomes and Management	64
Immune Checkpoint Inhibitor Therapy Aggravates T Cell–Driven Plaque Inflammation in Atherosclerosis	62
ATTR Amyloidosis: Current and Emerging Management Strategies	54
Incident Cardiovascular Disease Among Adults With Cancer	49
Strain Imaging in Cardio-Oncology	49
Risk of Atrial Fibrillation According to Cancer Type	49
Common Pathophysiology in Cancer, Atrial Fibrillation, Atherosclerosis, and Thrombosis	47
Early Cardiac Toxicity Associated With Post-Transplant Cyclophosphamide in Allogeneic Stem Cell Transplantation	46
Myocarditis Surveillance With High-Sensitivity Troponin I During Cancer Treatment With Immune Checkpoint Inhibitors	46
The Role of Cardioprotection in Cancer Therapy Cardiotoxicity	45
Direct Oral Anticoagulants in Patients With Active Cancer	40
Mitochondria-Rich Extracellular Vesicles Rescue Patient-Specific Cardiomyocytes From Doxorubicin Injury	39
Cardiac Adverse Events in EGFR-Mutated Non-Small Cell Lung Cancer Treated With Osimertinib	36
BSE and BCOS Guideline for Transthoracic Echocardiographic Assessment of Adult Cancer Patients Receiving Anthracyclines and/or Trastuzumab	33
Diuretic Dose and NYHA Functional Class Are Independent Predictors of Mortality in Patients With Transthyretin Cardiac Amyloidosis	32
Cardiac Disease in Childhood Cancer Survivors	32
Genetics of Anthracycline Cardiomyopathy in Cancer Survivors	31

Early Detection and Prediction of Anthracycline-Induced Right Ventricular Cardiotoxicity by 3-Dimensional Echocardiography	30
Doxorubicin-Induced Oxidative Stress and Endothelial Dysfunction in Conduit Arteries Is Prevented by Mitochondrial-Specific Antioxidant Treatment	29
Dual Angiotensin Receptor-Neprilysin Inhibition With Sacubitril/Valsartan Attenuates Systolic Dysfunction in Experimental Doxorubicin-Induced Cardiotoxicity	28
Arterial Thromboembolism in Cancer Patients	28
AL Amyloidosis: Current Chemotherapy and Immune Therapy Treatment Strategies	27
Coronary Artery Disease in Young Women After Radiation Therapy for Breast Cancer	27
Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients With Active Cancer	27
The Incidence, Risk Factors, and Outcomes With 5-Fluorouracil–Associated Coronary Vasospasm	26
Cardiovascular Safety of Degarelix Versus Leuprolide for Advanced Prostate Cancer	26
Electrophysiological Manifestations of Cardiac Amyloidosis	26
Immune Checkpoint Inhibitor Therapy in Oncology	25
Concomitant Transthyretin Amyloidosis and Severe Aortic Stenosis in Elderly Indian Population	24
Low QRS Voltages in Cardiac Amyloidosis	23
Magnetic Resonance Imaging to Detect Cardiovascular Effects of Cancer Therapy	23
Incremental Value of Global Longitudinal Strain for Predicting Survival in Patients With Advanced AL Amyloidosis	23
Cardiovascular Disease in Myeloproliferative Neoplasms	22
Atherosclerosis With Immune Checkpoint Inhibitor Therapy	21
Management of Immune Checkpoint Inhibitor–Induced Myocarditis	21
Patterns of Anticoagulation Use in Patients With Cancer With Atrial Fibrillation and/or Atrial Flutter	21
Racial and Ethnic Disparities in Cardio-Oncology	21
Cardio-Oncology Care in the Time of COVID-19 and the Role of Telehealth	20
Characterization of Immune Checkpoint Inhibitor-Related Cardiotoxicity in Lung Cancer Patients From a Rural Setting	20
Temporal Trends of Wild-Type Transthyretin Amyloid Cardiomyopathy in the Transthyretin Amyloidosis Outcomes Survey	20
Cancer Incidence and Mortality According to Pre-Existing Heart Failure in a Community-Based Cohort	20
Longitudinal Changes in Echocardiographic Parameters of Cardiac Function in Pediatric Cancer Survivors	20
Does Cardiovascular Mortality Overtake Cancer Mortality During Cancer Survivorship?	19
Atherosclerotic Cardiovascular Disease, Cancer, and Financial Toxicity Among Adults in the United States	19
Takotsubo Cardiomyopathy Associated With Checkpoint Inhibitor Therapy	18
Two Decades of Cardiac Amyloidosis	18
AL Amyloidosis for Cardiologists	18
Allogeneic Mesenchymal Cell Therapy in Anthracycline-Induced Cardiomyopathy Heart Failure Patients	17
A Proteomic Atlas of Cardiac Amyloid Plaques	17
Biomarker Trends, Incidence, and Outcomes of Immune Checkpoint Inhibitor–Induced Myocarditis	17
Heart Failure Associated With the Epidermal Growth Factor Receptor Inhibitor Osimertinib	16
How to Diagnose and Manage Patients With Fluoropyrimidine-Induced Chest Pain	16
Comprehensive Characterization of the Vascular Effects of Cisplatin-Based Chemotherapy in Patients With Testicular Cancer	16
Refining the 10-Year Prediction of Left Ventricular Systolic Dysfunction in Long-Term Survivors of Childhood Cancer	16
Cardiac Computed Tomography in Cardio-Oncology	15
Machine Learning Identifies Clinical and Genetic Factors Associated With Anthracycline Cardiotoxicity in Pediatric Cancer Survivors	15
Impact of Social Vulnerability on Comorbid Cancer and Cardiovascular Disease Mortality in the United States	15
Role of Physical Activity and Cardiac Rehabilitation in Patients Undergoing Hematopoietic Stem Cell Transplantation	15
Impact of Cancer Therapy-Related Cardiac Dysfunction on Risk of Heart Failure in Pregnancy	15
Lifestyle and Cardiovascular Risk Factors Associated With Heart Failure Subtypes in Postmenopausal Breast Cancer Survivors	15
Immune Checkpoint Inhibitor-Associated Myocarditis With Persistent Troponin Elevation Despite Abatacept and Prolonged Immunosuppression	15
Cardiotoxicity Surveillance and Risk of Heart Failure During HER2 Targeted Therapy	14
Oncotherapeutic Protein Kinase Inhibitors Associated With Pro-Arrhythmic Liability	14
How to Diagnose and Manage QT Prolongation in Cancer Patients	14
The Role of Healthy Lifestyle in Cancer Incidence and Temporal Transitions to Cardiometabolic Disease	13
The TICONC (Ticagrelor-Oncology) Study	13
Cardiometabolic Comorbidities in Cancer Survivors	13

Suboptimal Use of Cardioprotective Medications in Patients With a History of Cancer	13
How to Manage Atrial Fibrillation Secondary to Ibrutinib	13
Primer on Biomarker Discovery in Cardio-Oncology	13
Reduced Cardiorespiratory Fitness and Increased Cardiovascular Mortality After Prolonged Androgen Deprivation Therapy for Prostate Cancer	13
Using Behavioral Economics and Technology to Improve Outcomes in Cardio-Oncology	13
Transcatheter Compared With Surgical Aortic Valve Replacement in Patients With Previous Chest-Directed Radiation Therapy	13
Mechanistic and Clinical Overview Cardiovascular Toxicity of BRAF and MEK Inhibitors	13
Prevalence, Treatment, and Prognosis of Tumor Thrombi in Renal Cell Carcinoma	12
Physical Activity and Cardiac Function in Long-Term Breast Cancer Survivors	12
Cardiovascular Disease Among Patients With AML and CHIP-Related Mutations	11
Optimal Timing of a Physical Exercise Intervention to Improve Cardiorespiratory Fitness	11
Contribution of Polygenic Risk to Hypertension Among Long-Term Survivors of Childhood Cancer	11
Immune Checkpoint Inhibitor Myocarditis Treatment Strategies and Future Directions	11
Acute Heart Failure 29 Years After Treatment for Childhood Cancer	11
Detection of Subclinical Cardiovascular Disease by Cardiovascular Magnetic Resonance in Lymphoma Survivors	11
Risk of Cancer After Diagnosis of Cardiovascular Disease	11
How to Treat Prostate Cancer With Androgen Deprivation and Minimize Cardiovascular Risk	11
Racial and Ethnic Disparities in All-Cause and Cardiovascular Mortality Among Cancer Patients in the U.S.	11
Cardiac Magnetic Resonance for Early Detection of Radiation Therapy-Induced Cardiotoxicity in a Small Animal Model	10
Prevalence of Cardiovascular Disease in Patients With Potentially Curable Malignancies	10
Permissive Cardiotoxicity	10
Computed Tomographic Angiography Assessment of Epicardial Coronary Vasoreactivity for Early Detection of Doxorubicin-Induced Cardiotoxicity	10
The Association of Sodium-Glucose Cotransporter 2 Inhibitors With Cardiovascular Outcomes in Anthracycline-Treated Patients With Cancer	10
Cardiac Biomarkers During Cancer Therapy	10
Clonal Hematopoiesis and JAK2V617F Mutations in Patients With Cardiovascular Disease	9
Impact of Cancer in Patients Undergoing Transcatheter Aortic Valve Replacement	9
COVID-19 Clinical Trials	9
Modified Routine Cardiac Imaging Surveillance of Adult Cancer Patients and Survivors During the COVID-19 Pandemic	9
Effect of Tafamidis on Serum Transthyretin Levels in Non-Trial Patients With Transthyretin Amyloid Cardiomyopathy	9
Florida Inter-Specialty Collaborative Project to Improve Cardio-Oncology Awareness and Identify Existing Knowledge Gaps	9
Cardiotoxicity of T-Cell Antineoplastic Therapies	9
Longitudinal Strain and Troponin I Elevation in Patients Undergoing Immune Checkpoint Inhibitor Therapy	9
Left Atrial Mechanics Associates With Paroxysmal Atrial Fibrillation in Light-Chain Amyloidosis Following Stem Cell Transplantation	9
Self-Reported Physical Activity, QoL, Cardiac Function, and Cardiorespiratory Fitness in Women With HER2+ Breast Cancer	8
Late-Onset Giant Cell Myocarditis Due to Enterovirus During Treatment With Immune Checkpoint Inhibitors	8
Delphi Panel Consensus Recommendations for Screening and Managing Childhood Cancer Survivors at Risk for Cardiomyopathy	8
Screening for Coronary Artery Disease in Cancer Survivors	8
Left Ventricular Systolic Function in Long-Term Survivors of Allogeneic Hematopoietic Stem Cell Transplantation	8
Major Adverse Cardiovascular Events in Patients With Renal Cell Carcinoma Treated With Targeted Therapies	8
Clinical, Echocardiographic, and Biomarker Associations With Impaired Cardiorespiratory Fitness Early After HER2-Targeted Breast Cancer Therapy	8
Cardiac Transplantation and Mechanical Circulatory Support in Amyloidosis	8
Plasma Hepatocyte Growth Factor for Diagnosis and Prognosis in Light Chain and Transthyretin Cardiac Amyloidosis	7
Repeated Remote Ischemic Conditioning Reduces Doxorubicin-Induced Cardiotoxicity	7
Pre-Existing Autoimmune Disease Increases the Risk of Cardiovascular and Noncardiovascular Events After Immunotherapy	7
From Cardiac Anthracycline Accumulation to Real-Life Risk for Early Diastolic Dysfunction	7
Potential Applications for Targeted Gene Therapy to Protect Against Anthracycline Cardiotoxicity	7
Acute Effects of Ibrutinib on Ventricular Arrhythmia in Spontaneously Hypertensive Rats	7
Outcomes by Cardiac Stage in Patients With Newly Diagnosed AL Amyloidosis	7
Time-Restricted Eating to Reduce Cardiovascular Risk Among Older Breast Cancer Survivors	7
3-Year Follow-Up of Radiation-Associated Changes in Diastolic Function by Speckle Tracking Echocardiography	7
Uridine Triacetate for Severe Fluoropyrimidine Cardiotoxicity in a Patient With Thymidylate Synthase Gene Variants	7
How to Manage Patients With Cardiac Implantable Electronic Devices Undergoing Radiation Therapy	7
Association of Cardiometabolic Disease With Cancer in the Community	7
Cardiology Involvement in Patients With Breast Cancer Treated With Trastuzumab	6
Cardiovascular Toxicity of Proteasome Inhibitors: Underlying Mechanisms and Management Strategies	6
Cardiac Toxicity of Alectinib in Patients With ALK+ Lung Cancer	6
Prospective Evaluation of Malignancy in 17,708 Patients Randomized to Ezetimibe Versus Placebo	6
Late-Onset Immunotherapy-Induced Myocarditis 2 Years After Checkpoint Inhibitor Initiation	6
Prognosis of Transthyretin Cardiac Amyloidosis Without Heart Failure Symptoms	6
Prediction of Lifetime and 10-Year Risk of Cancer in Individual Patients With Established Cardiovascular Disease	6
Direct Oral Anticoagulants in Patients With Cancer and Nonvalvular Atrial Fibrillation	6
Cardiac Magnetic Resonance in Cardio-Oncology	6
Evidence of Concurrent Light Chain and Transthyretin Cardiac Amyloidosis in 2 Patients	6
Financial Toxicity in Cancer and Cardiovascular Disease	6
Outcomes by Class of Anticoagulant Use for Nonvalvular Atrial Fibrillation in Patients With Active Cancer	6
Performance Status and Long-Term Outcomes in Cancer-Associated Pulmonary Embolism	6
5-Fluorouracil Cardiotoxicity	5
Heart Transplantation in Adriamycin-Associated Cardiomyopathy in the Contemporary Era of Advanced Heart Failure Therapies	5
Cardiovascular Morbidity in Monoclonal Gammopathy of Undetermined Significance	5
Healthy Lifestyle Benefits Both Cancer and Cardiovascular Disease	5
Cardiovascular Toxicity With Cisplatin in Patients With Testicular Cancer	5
Cardiac Interventions in Patients With Active, Advanced Solid and Hematologic Malignancies	5
Risk for Myocardial Infarction Following 5-Fluorouracil Treatment in Patients With Gastrointestinal Cancer	5
Physician Knowledge and Awareness About Cardiac Amyloidosis in the Middle East and Gulf Region	5
Research Quality and Impact of Cardiac Rehabilitation in Cancer Survivors	5
Anthracycline-Induced Cardiotoxicity	5
Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation and Cancer	5
Combat Doxorubicin Cardiotoxicity With the Power of Mitochondria Transfer	5
How to Perform Pericardiocentesis in Cancer Patients With Thrombocytopenia	5
Cardio-Oncology in Japan	5

Effectiveness and Safety of Rivaroxaban and Low Molecular Weight Heparin in Cancer-Associated Venous Thromboembolism	5
Radiation-Associated Coronary Disease in Young Cancer Survivors	5
Atrial Fibrillation Incidence Associated With Exposure to Anticancer Drugs Used as Monotherapy in Clinical Trials	5
How to Diagnose and Manage Radiation Cardiotoxicity	5
Aortic Stenosis and the Tyrosine Kinase Inhibitor Nilotinib in Chronic Myeloid Leukemia	5
Left Ventricular Assist Devices in Patients With Active Malignancies	4
Validity of Estimated Cardiorespiratory Fitness in Patients With Primary Breast Cancer	4
Genomic Screening for Pathogenic Transthyretin Variants Finds Evidence of Underdiagnosed Amyloid Cardiomyopathy From Health Records	4
Pharmacovigilance Analysis of Heart Failure Associated With Anti-HER2 Monotherapies and Combination Regimens for Cancer	4
Considerations of Competing Risks Analysis in Cardio-Oncology Studies	4
Cancer Treatment-Related Cardiovascular Toxicity in Gynecologic Malignancies	4
Mistaken Identity	4
Amyloidosis and 30-Day Outcomes Among Patients With Heart Failure	4
Outcomes of Cancer Patients Undergoing Transcatheter Aortic Valve Replacement	4
Cardioprotection in Patients at High Risk of Anthracycline-Induced Cardiotoxicity	4
Arterial Thromboembolism in Patients With AF and CHA2DS2-VASc Score 0-2 With and Without Cancer	4
Cardiovascular Burden and Adverse Events in Patients With Esophageal Cancer Treated With Chemoradiation for Curative Intent	4
Cisplatin-Associated Aortic Thrombosis	4
Successful CAR T Cell Therapy in a Heart and Kidney Transplant Recipient With Refractory PTLD	4
Overcoming LGBTQI+ Disparities in Cardio-Oncology	4
Toward Population-Based Genetic Screening for Hereditary Amyloidosis	3
How to Manage Cisplatin-Based Chemotherapy–Related Cardiovascular Disease in Patients With Testicular Cancer	3
Remote Ischemic Conditioning in Pediatric Cancer Patients Receiving Anthracycline Chemotherapy	3
Aging, Aortic Stenosis, and Transthyretin Cardiac Amyloidosis	3
Lymphoma Severity and Type Are Associated With Aortic FDG Uptake by 18F-FDG PET/CT Imaging	3
Chest Pain in Cancer Patients	3
Repeated Remote Ischemic Conditioning Protects Against Doxorubicin Cardiotoxicity	3
Association of Midlife Cardiovascular Health and Subsequent Change in Cardiovascular Health With Incident Cancer	3
Cellular and Molecular Mechanisms of MEK1 Inhibitor–Induced Cardiotoxicity	3
Cardiovascular Associations With Monoclonal Gammopathy of Undetermined Significance	3
Cardio-Oncology in China	3
How to Follow, Manage and Treat Cardiac Dysfunction in Patients With Her2+ Breast Cancer	3
Reversible Myocardial Edema Secondary to Tagraxofusp-Induced Capillary Leak Syndrome	3
CardioMEMS-Guided CAR T Cell Therapy for Lymphoma in a Patient With Anthracycline-Induced Cardiomyopathy	3
How to Treat Renal Cell Carcinoma	3
Implementation of Cardio-Oncology Training for Cardiology Fellows	3
Amyloid Cardiomyopathy	3
The Burden of Uncontrolled Cardiovascular Risk Factors in Men With Prostate Cancer	3
Real-World Evidence in Cardio-Oncology	3
#Cardioonc	3
Cardio-Oncology in Brazil	3
Cardiovascular Concerns in the Management of Esophageal Cancer Patients	3
Contribution of Genome-Wide Polygenic Score to Risk of Coronary Artery Disease in Childhood Cancer Survivors	3
ESC Cardio-Oncology Guidelines	3
The Potential Impact of the 2022 ESC Cardio-Oncology Guidelines on Clinical Practice in China	3
Cardiac Tamponade as the First Manifestation of Erdheim-Chester Disease	3
Cytokines Are at the Heart of It	3
Infiltrative Lymphoma-Associated Bradycardia and Cardiac Conduction Abnormalities	3
Predicting Adverse Cardiac Events After Radiotherapy for Locally Advanced Non–Small Cell Lung Cancer	3
What Is the Evidence of the Diagnostic Criteria and Screening of Immune Checkpoint Inhibitor–Induced Myocarditis?	3
Evolving Treatment Options for Cancer-Related Venous Thromboembolism	3
Atrial Involvement in Cardiac Amyloidosis	3
ROCK and Rolling Towards Predicting BCR-ABL Kinase Inhibitor-Induced Vascular Toxicity	2
How Common Is Pre-Existing Cardiovascular Disease in Cancer Patients	2
Multimodality Treatment for Advanced Cervical Cancer With Isolated Metastasis to Interventricular Septum of the Heart	2
Fulminant Cardiotoxicity in a Patient With Cardiac Lymphoma Treated With CAR-T Cells	2
TET2 Clonal Hematopoiesis Is Associated With Anthracycline-Induced Cardiotoxicity in Patients With Lymphoma	2
Impact of Cardiopulmonary Resuscitation on Survival in Cancer Patients	2
Anthracyclines and Biomarkers of Myocardial Injury	2
Delayed Diagnosis and Recovery of Fulminant Immune Checkpoint Inhibitor-Associated Myocarditis on VA-ECMO Support	2
Phenotypic Spectrum of Transthyretin Cardiac Amyloidosis in a Family	2
Clinical Practice Guidelines in Cardio-Oncology	2
Atrial Fibrillation and Cancer	2
Vo2peak in Adult Survivors of Hodgkin Lymphoma	2
#JACCCardioOnc	2
LAG3 Regulates T Cell Activation and Plaque Infiltration in Atherosclerotic Mice	2
How to Treat Adult Acute Myeloid Leukemia	2
Ibrutinib Is Associated With Increased Cardiovascular Events and Major Bleeding in Older CLL Patients	2
Ventricular Arrhythmias Due to Glomangiosarcoma Cardiac Metastases	2
Cancer-Associated Thrombosis	2
Evaluating Anticoagulant Strategies for Atrial Fibrillation in Patients With Cancer	2
Long-Term Outcomes Following Myocardial Infarction in Young Adult Survivors of Hodgkin Lymphoma	2
How to Treat Breast Cancer After Childhood Cancer	2
Inflammatory Biomarkers to Detect Immune Checkpoint Inhibitor-Associated Cardiotoxicity in Lung Cancer Patients	2
Addressing Cardiovascular Risk of Prostate Cancer Hormonal Therapy	2
Immune Checkpoint Inhibitors’ Effects on Calcified Aortic Plaques in Melanoma Survivors	2
How to Treat Diffuse Large B-Cell Lymphoma	2
Longitudinal Right Ventricular Systolic Function Changes in Breast Cancer Patients Treated With Cardiotoxic Cancer Therapy	2
Outcomes of Patients With Myeloproliferative Neoplasms Admitted With Myocardial Infarction	2
Evaluation of Senescence and Its Prevention in Doxorubicin-Induced Cardiotoxicity Using Dynamic Engineered Heart Tissues	2
Tumor Genetics Are Thrombogenic	2
Anticoagulation for the Prevention of Arterial Thrombosis in Ambulatory Cancer Patients	2
ATTR Cardiomyopathy Meets Multiple Myeloma	2
Working Together to Advance Cardio-Oncology in China	2
Remote Ischemic Conditioning for Anthracycline Cardiotoxicity	2
Targeting the Cardiotoxicity of Epidermal Growth Factor Receptor Inhibitors	2
Assessment of Left Ventricular, Right Ventricular, and Left Atrial Strain in Light-Chain Amyloidosis	2
How to Manage and Monitor Cardiac Dysfunction in Patients With Metastatic HER2-Positive Breast Cancer	2
The European Society of Cardiology Cardio-Oncology Guidelines	2
Racial Differences in Chronic Stress/Allostatic Load Variation Due to Androgen Deprivation Therapy in Prostate Cancer	2
Prevalence of Diastolic Dysfunction in Adult Survivors of Childhood Cancer	2
Understanding Race and Ethnicity in Cancer and CV Disease	2
Involvement of Rho-Associated Coiled-Coil Containing Kinase (ROCK) in BCR-ABL1 Tyrosine Kinase Inhibitor Cardiovascular Toxicity	2
The Association of Metformin With Heart Failure in Patients With Diabetes Mellitus Receiving Anthracycline Chemotherapy	2
Management of Amyloid Cardiomyopathy in Resource-Constrained Settings	1